Meanwhile, the FDA in the US is recommending infants get a new monoclonal antibody treatment to ward off RSV infection. The government here has also recently released a five-year roadmap on tackling rheumatic fever and rheumatic heart disease.
This is a companion discussion topic for the original entry at https://www.sciencemediacentre.co.nz/2023/06/16/kids-could-be-worst-off-in-winter-illness-surge-expert-qa/